Literature DB >> 21534151

An ethically justified framework for clinical investigation to benefit pregnant and fetal patients.

Frank A Chervenak1, Laurence B McCullough.   

Abstract

Research to improve the health of pregnant and fetal patients presents ethical challenges to clinical investigators, institutional review boards, funding agencies, and data safety and monitoring boards. The Common Rule sets out requirements that such research must satisfy but no ethical framework to guide their application. We provide such an ethical framework, based on the ethical concept of the fetus as a patient. We offer criteria for innovation and for Phase I and II and then for Phase III clinical trials to improve the health of pregnant patients and of fetal patients and also criteria to responsibly manage the transition from investigation to clinical practice. Basing ethical criteria for research involving pregnant women on the ethical concept of the fetus as a patient insulates the proposed ethical framework and therefore research on pregnant women from the divisive and politicized concepts and discourses of personhood, fetal rights, and unborn child.

Entities:  

Mesh:

Year:  2011        PMID: 21534151     DOI: 10.1080/15265161.2011.562595

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  8 in total

1.  Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template.

Authors:  Richard H Beigi; Lisa Noguchi; Gina Brown; Jeanna Piper; D Heather Watts
Journal:  J Womens Health (Larchmt)       Date:  2013-06-29       Impact factor: 2.681

2.  How should risks and benefits be balanced in research involving pregnant women and fetuses?

Authors:  Carson Strong
Journal:  IRB       Date:  2011 Nov-Dec

Review 3.  Ethics of studies of drugs in pregnancy.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

Review 4.  Human teratogens update 2011: can we ensure safety during pregnancy?

Authors:  Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-13

5.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

6.  Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.

Authors:  Amita Gupta; Jyoti S Mathad; Susan M Abdel-Rahman; Jessica D Albano; Radu Botgros; Vikki Brown; Renee S Browning; Liza Dawson; Kelly E Dooley; Devasena Gnanashanmugam; Beatriz Grinsztejn; Sonia Hernandez-Diaz; Patrick Jean-Philippe; Peter Kim; Anne D Lyerly; Mark Mirochnick; Lynne M Mofenson; Grace Montepiedra; Jeanna Piper; Leyla Sahin; Radojka Savic; Betsy Smith; Hans Spiegel; Soumya Swaminathan; D Heather Watts; Amina White
Journal:  Clin Infect Dis       Date:  2015-12-09       Impact factor: 9.079

7.  A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials.

Authors:  Saskia Hendriks; Christine Grady; David Wasserman; David Wendler; Diana W Bianchi; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2021-01-16       Impact factor: 11.229

8.  Maternal-Fetal Surgery: Does Recognising Fetal Patienthood Pose a Threat to Pregnant Women's Autonomy?

Authors:  Dunja Begović
Journal:  Health Care Anal       Date:  2021-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.